WORLDSymposium™ 2025
Feb 6, 2025
Supporting Materials
Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing Phase 1/2 study (STAAR)
Derralynn Hughes, Royal Free London Hospital, London, UK
• Platform Presentation: Thursday, February 6, 2025 – 9:30am PT
• Poster Session: Thursday, February 6, 2025 – 3:30-5:30pm PT (Poster: 146)